Daniel F Hanley

• Johns Hopkins University

  Div. dir. brain inj. outcomes

Sources: reporter.nih.gov

• National Institute on Aging

  UG3, STORM: Proof-of-concept STudies of ORal MW189, a novel anti-neuroinflammatory drug, in Alzheimer's patients, UG3AG104111, 2026–2028, 25 Aug 2026

• National Institute on Aging

  R01, Metformin in Alzheimer's dementia Prevention (MAP), R01AG062624, 2019–2027, 14 Jul 2025

Sources: reporter.nih.gov